The U.S. Food and Drug Administration (FDA) has agreed to review a supplemental application seeking authorization of once-monthly maintenance dosing…
Articles by Marisa Wexler, MS
An advisory committee to the U.S. Food and Drug Administration (FDA) has unanimously voted in favor of donanemab, an…
Eisai has started a rolling application seeking U.S. approval of a subcutaneous, or under-the-skin, injection version of Leqembi…
A U.S. Food and Drug Administration (FDA) advisory committee will meet June 10 to review clinical trial data related to…
Two Phase 3 clinical trials are testing the effectiveness of simufilam, an experimental oral therapy that’s…
Biogen is discontinuing development and commercialization of its controversial Alzheimer’s disease treatment Aduhelm (aducanumab) — a move that’s…
A commercially available blood test, sold by ALZpath, can identify with high accuracy Alzheimer’s disease patients who are…
The cell therapy candidate Lomecel-B significantly improved cognitive function and reduced brain volume loss relative to a placebo in a…
A rare variant in the APOE gene, known as the Christchurch mutation or APOE3ch, can protect against the development of…
A novel technique that detects DNA from dead nerve cells in the blood may help diagnose Alzheimer’s disease and…